Cubist Systematic Strategies, LLC Senseonics Holdings, Inc. Transaction History

Cubist Systematic Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.32 - $0.49 $29,588 - $45,306	92,463 Added 22.26%	507,867 $177,000
Q2 2024 Aug 14, 2024	BUY	$0.37 - $0.52 $31,635 - $44,460	85,501 Added 25.92%	415,404 $166,000
Q1 2024 May 15, 2024	BUY	$0.5 - $0.73 $993 - $1,450	1,987 Added 0.61%	329,903 $174,000
Q4 2023 Feb 14, 2024	BUY	$0.48 - $0.7 $56,076 - $81,777	116,825 Added 55.34%	327,916 $186,000
Q3 2023 Nov 14, 2023	SELL	$0.5 - $1.05 $575,486 - $1.21 Million	-1,150,972 Reduced 84.5%	211,091 $126,000
Q2 2023 Aug 14, 2023	BUY	$0.55 - $0.89 $749,134 - $1.21 Million	1,362,063 New	1,362,063 $1.04 Million
Q1 2022 May 16, 2022	SELL	$1.54 - $3.71 $31,371 - $75,576	-20,371 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.58 - $3.91 $3,250 - $4,926	-1,260 Reduced 5.82%	20,371 $54,000
Q3 2021 Nov 15, 2021	SELL	$2.77 - $4.05 $390,063 - $570,308	-140,817 Reduced 86.68%	21,631 $73,000
Q2 2021 Aug 16, 2021	BUY	$1.71 - $4.14 $188,182 - $455,598	110,048 Added 210.02%	162,448 $624,000
Q1 2021 May 17, 2021	BUY	$0.85 - $5.27 $44,540 - $276,148	52,400 New	52,400 $138,000

138

80.6M

418K

219K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $275M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.